-
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells
Zhang, L., Atencia Taboada, L., Baglamis, S., de Kroon, M., Elshout, C., Ramesh, P., Helderman, R. F. C. P. A., Torang, A., Cameron, K., van Driel, M. S., Wouters, V. M., van Neerven, S. M. & Medema, J. P., 1 Dec 2025, In: Oncogenesis. 14, 1, 25.Research output: Contribution to journal › Article* › Academic › peer-review
-
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation
van den Beukel, M. D., Zhang, L., van der Meulen, S., Borggreven, N. V., Nugteren, S., Brouwer, M. C., Pouw, R. B., Gelderman, K. A., de Ru, A. H., Janssen, G. M. C., van Veelen, P. A., Knevel, R., Parren, P. W. H. I. & Trouw, L. A., 1 Jul 2025, In: Journal of autoimmunity. 155, 103444.Research output: Contribution to journal › Article* › Academic › peer-review
-
Exploring novel sensitizers: Advancing BH3 mimetic efficacy in colorectal cancer therapeutics
Zhang, L., 2025, 164 p.Research output: PhD thesis › Thesis, fully internal
- All publications
